Skip to main content
. Author manuscript; available in PMC: 2021 Apr 5.
Published in final edited form as: Bone. 2020 Oct 22;142:115705. doi: 10.1016/j.bone.2020.115705

Fig. 6.

Fig. 6.

Expression of DNM3OS and DNM3 in patient and control fibroblasts. A, B. Relative expression of DNM3OS and DNM3 in the two patient sample fibroblasts and control, non-diseased fibroblasts at baseline. C, D. Relative expression of DNM3OS and DNM3 in patient and control fibroblasts following 3 days of osteogenic induction. Gene levels were expressed as relative abundance to PPIA. Experiments were carried out in triplicate and a Student’s t-test was used to determine statistical significance in mRNA expression between the control sample and each of the patient samples (*p < 0.05).